Research Article

G-1639A but Not C1173T VKORC1 Gene Polymorphism Is Related to Ischemic Stroke and Its Various Risk Factors in Ukrainian Population

Table 6

Clinical characteristics of IS patients with different VKORC1 G-1639A genotypes.

ParameterG/GG/AA/ATotal

497942170
BMI27.9 ± 3.928.6 ± 4.927.8 ± 3.628.2 ± 4.30.533
Systolic BP, mmHg164.1 ± 32.5169.7 ± 29.3165.2 ± 24.8166.9 ± 29.20.522
Diastolic BP, mmHg94.9 ± 15.396.4 ± 15.493.9 ± 16.495.4 ± 15.60.692
Total cholesterol, mmol/L5.09 ± 1.55.02 ± 1.55.06 ± 1.65.05 ± 1.50.961
HDL-cholesterol, mmol/L1.07 ± 0.31.01 ± 0.30.99 ± 0.31.02 ± 0.30.452
LDL-cholesterol, mmol/L3.29 ± 1.43.24 ± 1.43.24 ± 1.53.26 ± 1.40.979
Triglyceride, mmol/L1.62 ± 0.71.69 ± 0.81.80 ± 0.91.70 ± 0.80.588
Prothrombin time, s9.68 ± 1.99.51 ± 2.09.17 ± 2.29.48 ± 2.00.483
Thrombin time, s16.48 ± 3.217.25 ± 4.115.26 ± 2.516.54 ± 3.60.013
Fibrinogen, g/L3.79 ± 1.33.89 ± 1.34.17 ± 1.13.93 ± 1.20.301
Fasting glucose, mmol/L5.82 ± 1.46.11 ± 1.65.70 ± 1.55.92 ± 1.50.312

: number of subjects; HDL: high density lipoprotein; LDL: low density lipoprotein.
for G/G genotype, for G/A genotype, and for A/A genotype.
Significant difference between A/A and G/A genotypes () by Bonferroni’s correction.